Elijah Dale - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Elijah Dale's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Elijah Dale

Elijah Dale

Verified

Reporter, Alliance News

Wokingham

Final Covers

communitygovernment business development

Journalist Type

Seniority Positions

Industries

Medium Formats

Content

Total articles 3259

  • Daiichi Sankyo and AstraZeneca secure EU approval for Datroway

    By Elijah Dale| MarketScreener Verified (Alliance News) - Daiichi Sankyo Co Ltd and AstraZeneca PLC on Tuesday said Datroway has secured EU approval to treat breast cancer patients. Daiichi Sankyo, a Tokyo-based pharmaceutical company, and AstraZeneca, a Cambridge-based pharmaceutical firm agreed to jointly develop and commercialise Datroway in July 2020. Daiichi Sankyo is responsible for the manufacturing and supply of Datroway and retains exclusive rights for the treatment in the Japanese market.

    By Elijah Dale · MarketScreener

    Apr. 09, 2025

  • Prudential annual profit rises 41% amid solid revenue, lifts dividend

    By Elijah Dale| Morningstar UK@ (Alliance News) - Prudential PLC on Wednesday reported strong annual profit growth, boosted by higher insurance revenue with robust performance across key Asian markets, prompting an increased dividend. The London-based insurance firm & asset manager said pretax profit increased 41% to USD2.95 billion in full-year 2024 from USD2.10 billion a year prior. Basic earnings per share after tax were 84.1 US cents, up 35% from 62.1c.

    By Elijah Dale · Morningstar UK

    Mar. 20, 2025

  • Daiichi Sankyo and AstraZeneca secure EU approval for Datroway

    By Elijah Dale| MarketScreener Verified (Alliance News) - Daiichi Sankyo Co Ltd and AstraZeneca PLC on Tuesday said Datroway has secured EU approval to treat breast cancer patients. Daiichi Sankyo, a Tokyo-based pharmaceutical company, and AstraZeneca, a Cambridge-based pharmaceutical firm agreed to jointly develop and commercialise Datroway in July 2020. Daiichi Sankyo is responsible for the manufacturing and supply of Datroway and retains exclusive rights for the treatment in the Japanese market.

    By Elijah Dale · MarketScreener

    Apr. 09, 2025

As seen in

Company Info

Alliance News

'+1 330-821-1200

Founded: 1888